ClinicalTrials.govpublic full text
A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults
hiv infections, hiv-1, dose-response relationship, drug, drug therapy, combination, vx 478, anti-hiv agents, pentafuside, abacavir, efavirenz, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 992730
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.